059210 — Metabiomed Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩105bn
Enterprise Value
KR₩110bn
Revenue
KR₩94bn

Annual balance sheet for Metabiomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21,044	15,916	19,141	16,810	54,298
Net Total Accounts Receivable
Net Total Receivables	12,181	13,047	14,504	14,534	17,279
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	52,123	48,203	50,976	49,924	93,957
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	42,726	39,278	52,123	59,086	64,099
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	107,856	103,128	121,072	130,124	177,295
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	47,410	38,161	44,817	44,471	73,597
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	59,878	44,805	60,481	60,077	83,956
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	47,978	58,323	60,591	70,048	93,339
Total Liabilities & Shareholders' Equity	107,856	103,128	121,072	130,124	177,295
Total Common Shares Outstanding